Makers Of Impotence Drugs Fined $1M

Law360, New York (March 4, 2008, 12:00 AM EST) -- A federal judge ordered a Florida drugmaker to pay roughly $1 million in penalties for misbranding and marketing its erectile dysfunction products without regulatory approval.

Judge Mary Lisi of the U.S. District Court for Rhode Island fined White Broadman Inc. more than $794,000 on Friday. In addition, the judge fined the company's president, James Mienik, $205,000, and he and part-owner Paul Romano received one year of probation for marketing the Penetrex and Penetrin drugs.

Federal prosecutors began the case in October 2007, accusing White Broadman of...
To view the full article, register now.